Zimbabwe’s Multi-Million Dose Polio Shield: A Model for Southern Africa’s Health Security

In a powerful demonstration of regional solidarity and proactive public health, Zimbabwe has successfully spearheaded a multi-round, synchronized vaccination campaign, deploying nearly three million doses of the novel oral polio vaccine type 2 (nOPV2). This monumental effort is a critical component of a broader Southern African strategy to erect a formidable shield against the re-establishment of circulating vaccine-derived poliovirus type 2 (cVDPV2), showcasing Zimbabwe’s unwavering commitment to a polio-free future.

The urgency of these campaigns stems from the persistent threat of poliovirus re-emergence across the region. While Zimbabwe has made significant strides since declaring a cVDPV2 outbreak in October 2023 – achieving no new detections since June 2024 through rigorous nationwide campaigns and enhanced surveillance – the continued presence of outbreaks in neighboring countries poses a constant risk of cross-border importation. This vulnerability underscores why a localized success must be fortified by a coordinated regional response.

Recognizing that polio knows no borders, Zimbabwe joined forces with Mozambique, Malawi, Zambia, Namibia, and Botswana in a strategic subregional immunization drive. The initiative meticulously targeted 27 high-risk districts across nine provinces, prioritizing border communities and densely populated urban centers most susceptible to virus entry. These synchronized efforts focused on safeguarding children under the age of five, the most vulnerable demographic.

Under the steadfast leadership of Zimbabwe’s Ministry of Health and Child Care (MOHCC), the campaigns mobilized an impressive alliance of international support. Key partners included the World Health Organization (WHO), UNICEF, Rotary International, the United States Centers for Disease Control and Prevention (CDC), and other Global Polio Eradication Initiative (GPEI) partners. This collaborative framework saw over 6,000 dedicated personnel – encompassing healthcare workers, village health workers, community volunteers, and health managers – deployed on the ground. Additionally, nine national surge consultants provided crucial expertise across various critical areas, from surveillance and logistics to community engagement and data analytics.

Vaccine delivery employed a comprehensive approach, combining facility-based services with extensive community outreach. The primary strategy involved meticulous door-to-door vaccination, ensuring that teams reached every household. This direct engagement was pivotal in immunizing children who might otherwise have been missed, thereby sustaining high population immunity in targeted areas and drastically reducing the potential for poliovirus re-emergence and transmission.

The impact of this human-centered approach was clear. Sr. Chipangura, Nurse in Charge at Tariro Clinic in Harare South District, articulated the spirit of the effort: “The success of every vaccination campaign depends on teamwork. From activities carried out at health facilities to door-to-door outreach in communities, every health worker plays an important role in ensuring that children are protected against vaccine-preventable diseases. Seeing our teams work together to reach families and ensure that no child is missed gives me confidence that we can keep our communities safe from polio.”

The synchronized campaigns, conducted across three impactful rounds in April, June, and July, progressively improved in quality and operational performance. The first round saw 936,618 children vaccinated, followed by 997,941 in the second, and culminating with 1,025,806 children reached in the third. In total, nearly three million doses of nOPV2 were administered, significantly bolstering immunity among children in Zimbabwe’s most vulnerable districts.

Independent monitoring and Lot Quality Assurance Surveys (LQAS) consistently affirmed high vaccination coverage among eligible children. These rigorous assessments also informed subsequent quality improvement plans, leading to enhanced performance in hard-to-reach communities and more effective social mobilization efforts in later rounds.

Beyond the immediate vaccination efforts, this regional response has significantly strengthened Zimbabwe’s overall public health infrastructure. It has bolstered acute flaccid paralysis (AFP) and environmental surveillance systems, fostered crucial cross-border collaboration, supported routine immunization services, and reinforced monitoring and supervision mechanisms. Regular coordination meetings at both national and subregional levels have ensured seamless alignment of activities and swift resolution of any operational challenges.

Dr. Tiruneh Desta, WHO Representative to Zimbabwe, underscored the broader vision: “The fight against polio is a race to reach every child, everywhere, before the virus does. WHO remains committed to supporting the Government of Zimbabwe and partners through technical expertise, surveillance, operational coordination, and community engagement to ensure that life-saving vaccines reach all eligible children. Zimbabwe’s synchronized vaccination campaign reflects the power of regional solidarity and collective action in stopping poliovirus transmission. By strengthening population immunity and protecting children across communities and borders, Zimbabwe is making a significant contribution to the vision of a polio-free Southern Africa and bringing the world closer to achieving the goal of eradicating polio once and for all.”

As the synchronized regional response continues, Zimbabwe is intensifying its preparedness, surveillance, routine immunization, and community engagement efforts. Strict accountability for nOPV2 vaccine vials, proper waste management, and enhanced laboratory surveillance capacity remain paramount. This comprehensive, collaborative strategy represents not just a local success, but a vital step towards securing a polio-free future for children across Zimbabwe and the entirety of Southern Africa.